So many times as a physician, as a pharmacist, when people come to us, can you help me
Using a model of streptozotocin diabetes in rats in vivo and HT-22 cells in vitro, it was shown that GLP-1RA liraglutide improves the cognitive abilities of rats with diabetes mellitus and can have a protective effect by reducing oxidative stress, suppressing the expression of -secretase (BACE1) and -secretase, as well as reducing the deposition of -amyloid by triggering signaling mechanisms associated with NF-kB and ERK1/2 [30]
They tell the clinical team where to look, not what to prescribe
[13] [14] This cardiovascular profile has been extensively studied, with certain agents (liraglutide, semaglutide, dulaglutide) demonstrating cardiovascular outcome benefits in patients with established cardiovascular disease or multiple risk factors
Hepatology 22 (Pt
Yes, alternatives like semaglutide (Wegovy) and tirzepatide (Mounjaro) have shown significant weight loss results in clinical studies